Genrobotics, an Indian robotics firm specializing in automation of hazardous tasks, reported strong financials for FY26 with a 35% revenue increase and a near tripling of profit. The company aims to raise ₹150 crore in a Series B funding round to accelerate growth and expand production.
- Revenue up 35% to ₹43.7 Cr and PAT nearly tripled in FY26.
- Plans ₹150 Cr Series B funding to expand manufacturing and global reach.
- Focus on sanitation, medical, defence, and space robotics verticals.
What happened
Genrobotics, a Thiruvananthapuram-based robotics startup, reported significant financial growth in FY26, with operating revenue rising 35% to ₹43.7 crore and profit after tax increasing nearly threefold to ₹2.6 crore. EBITDA also grew strongly, along with improvements in profit margins, indicating enhanced operational efficiency.
The company is preparing for a ₹150 crore Series B funding round, following previous capital raises exceeding ₹100 crore. This new funding aims to support rapid expansion in production capacity as well as deepen Genrobotics’ presence internationally. Current manufacturing facilities span Kerala and Andhra Pradesh, with plans to add sites in Uttar Pradesh and Hyderabad.
Why it matters
Genrobotics is positioning itself as a leader in automating challenging and hazardous labor across multiple sectors, including sanitation, medical rehabilitation, defence, and space technology. Its flagship product, Bandicoot, which automates sewer cleaning, addresses critical safety challenges by reducing dangerous human exposure.
The startup’s growth reflects a strong product-market fit, supported by competitive pricing and improved manufacturing capabilities. With government contracts and a robust ₹155 crore revenue pipeline for FY27, Genrobotics is primed for rapid scaling, which could have broad implications for robotics adoption in India’s industrial and healthcare sectors.
What to watch next
In the upcoming fiscal year, Genrobotics targets over 5X revenue growth to ₹219.9 crore, alongside substantial increases in EBITDA and profit. The company aims to nearly double its manufacturing footprint and continue developing advanced robotics technologies, such as autonomous defence rovers and robotic arms for space applications.
Investors and industry watchers should track the Series B funding round’s progress, the startup’s geographic expansion including new production sites, and adoption across its verticals. Success in these areas will be critical for Genrobotics as it pursues its long-term goal of reaching ₹1,600 crore in annual revenue and scaling indigenous robotics capabilities in India.